Dendritic Cell and Natural Killer Cell Interactions in H

H 中树突状细胞和自然杀伤细胞的相互作用

基本信息

项目摘要

The interaction between natural killer (NK) cells and dendritic cells (DCs) during the innate immune response is thought to greatly impact the quality and strength of the subsequent antigen-specific adaptive immune response. Mechanisms whereby NK cell-DC (NK-DC) crosstalk occurs include reciprocal enhancement of cellular activation and maturation as well as NK cell-mediated elimination of immature DCs (iDCs). The first contact between immature iDCs and antigens occurs in peripheral tissue at sites of inflammation where iDCs are recruited from the bloodstream, driven by cytokine and chemokine signals produced by resident DCs and other cell types. After antigen uptake, iDCs undergo a maturation process that allows the resulting mature DCs (mDCs) to migrate to secondary lymphoid tissues where they prime an antigen-specific T cell response. NK cells have been found to be extremely important in optimizing the differentiation of mDCs in order to prime an effective antigen-specific adaptive immune response. This process requires both NK-DC interactions and NK cell secretion of specific cytokines. Under physiological conditions, the DC maturation program is induced directly by microbial signals as well as by activated NK cells performing a regulatory role. We show here that secretion of IFN-g, a potent inducer of DC differentiation, ??is significantly impaired when NK cells are exposed to autologous mDCs generated from viremic, but not aviremic, HIV-1 infected individuals. Moreover, it was recently demonstrated that the ability to promote DC maturation was essentially confined to NK cells expressing a KIRneg/NKG2Adull/NKp30pos phenotype. We reported that freshly purified NK cells from HIV-1 viremic individuals expressed increased levels of KIRs, while expression of NKG2A and NKp30 was extremely low or absent, particularly among the CD56neg NK cells, a subset present at very low frequencies in both aviremic HIV-1 infected patients and healthy donors. Given the association of these defects with the viremic state, our data suggest that HIV-1, directly or indirectly, interferes with the maturation process of DCs. In fact, despite the expression of cell surface markers associated with a mature phenotype, we found that mDCs derived from viremic patients exhibited several functional defects that could potentially impair the mDC-mediated activation of NK cells. Among these dysfunctional activities, we found that autologous mDCs generated from viremic HIV-1 infected subjects clearly exhibited a markedly impaired capacity to induce both NK cell proliferation and NK cell secretion of IFN-g?. IL-12 is an important cytokine for the activation and proliferation of NK cells. Thus, the reduced IL-12 production by mDCs generated from viremic HIV-1 infected individuals, as demonstrated in this study, may partially account for their defective priming of NK cells. Impairments in the early steps of DC-NK cell crosstalk result in a defect in the ability to limit HIV-1 spread at sites of tissue infection or in secondary lymphoid organs. The lower secretion of IL-10, an HIV-1 inhibitory cytokine in most systems, by mDCs as well as the reduced cytolytic activity of NK cells from HIV-1 infected viremic patients may impair inhibition of HIV-1 replication in the peripheral tissues. Furthermore, it has been shown that IL-10 inhibits the expression of DC co-stimulatory molecules, and, therefore, the weak production of IL-10 by mDCs generated from viremic HIV-1 infected individuals might in part contribute to the mature phenotype of the markedly dysfunctional mDCs. A unique and perhaps more important mechanism through which NK cells are thought to impact the quality of the DCs undergoing maturation in response to antigen uptake is by killing iDCs that failed their maturation program. A recent study showed that DCs generated from viremic HIV-1 infected patients can escape lysis by autologous NK cells, but the underlying cause(s) of this escape have not been identified. In the present study, we delineate the cellular mechanisms that account for impaired NK cell-mediated lysis of autologous iDCs and show that this phenomenon is restricted to those HIV-1-infected individuals with persistent high viremia. Our data demonstrate that the markedly impaired expression/secretion and function of NKp30 and TRAIL largely account for the highly defective NK cell mediated lysis of autologous iDCs generated from viremic HIV-1 infected subjects. Moreover, we show that, within this study group, the high expansion of CD56neg NK cells expressing the unusual KIRpos/NKG2Aneg/NKp30neg/TRAILneg phenotype, a subset present at very low frequencies in either aviremic HIV-1 infected patients or healthy donors, likely explains why this defective elimination of autologous iDCs by NK cells is confined to HIV-1 positive viremic patients. This NK-DC crosstalk represents the proposed mechanism by which the innate immunity is able to prime an effective adaptive immune response in secondary lymphoid organs. The highly defective bidirectional NK-DC crosstalk in chronically HIV-1-infected viremic individuals compared with HIV-1 aviremic patients and uninfected control subjects likely contributes, in the context of HIV-1 pathogenesis, to the escape of virus from a coordinated innate and adaptive immune response.
天然杀伤(NK)细胞和树突状细胞(DC)在先天免疫应答期间的相互作用被认为极大地影响随后的抗原特异性适应性免疫应答的质量和强度。NK细胞-DC(NK-DC)串扰发生的机制包括细胞活化和成熟的相互增强以及NK细胞介导的未成熟DC(iDC)的消除。未成熟的iDC和抗原之间的第一次接触发生在炎症部位的外周组织中,其中iDC由驻留DC和其他细胞类型产生的细胞因子和趋化因子信号驱动从血流中募集。在抗原摄取后,iDC经历成熟过程,其允许所得成熟DC(mDC)迁移至次级淋巴组织,在那里它们引发抗原特异性T细胞应答。已经发现NK细胞在优化mDC的分化以引发有效的抗原特异性适应性免疫应答中极其重要。该过程需要NK-DC相互作用和NK细胞分泌特异性细胞因子。 在生理条件下,DC成熟程序直接由微生物信号以及由活化的NK细胞执行调节作用诱导。我们在这里表明,分泌IFN-γ,一个有效的诱导DC分化,??当NK细胞暴露于由病毒血症而非病毒血症的HIV-1感染个体产生的自体mDC时,此外,最近证明促进DC成熟的能力基本上限于表达KIRneg/NKG 2Adull/NKp 30 pos表型的NK细胞。我们报道了来自HIV-1病毒血症个体的新鲜纯化的NK细胞表达增加的KIR水平,而NKG 2A和NKp 30的表达极低或不存在,特别是在CD 56阴性NK细胞中,这是一个在HIV-1病毒血症患者和健康供体中以非常低的频率存在的亚群。考虑到这些缺陷与病毒血症状态的相关性,我们的数据表明HIV-1直接或间接地干扰了DC的成熟过程。事实上,尽管与成熟表型相关的细胞表面标志物的表达,我们发现,来自病毒血症患者的mDC表现出几个功能缺陷,可能会损害mDC介导的NK细胞活化。在这些功能障碍的活动中,我们发现从病毒血症HIV-1感染受试者产生的自体mDC明显表现出诱导NK细胞增殖和NK细胞分泌IFN-g?的能力明显受损。IL-12是NK细胞活化和增殖的重要细胞因子。因此,如本研究所示,由病毒血症的HIV-1感染个体产生的mDC产生的IL-12的减少可能部分地解释了它们对NK细胞的缺陷性引发。 DC-NK细胞串扰的早期步骤中的损伤导致在组织感染部位或次级淋巴器官中限制HIV-1传播的能力的缺陷。mDC分泌的IL-10(在大多数系统中的HIV-1抑制性细胞因子)较低以及来自HIV-1感染的病毒血症患者的NK细胞的细胞溶解活性降低可能损害外周组织中HIV-1复制的抑制。此外,已经显示IL-10抑制DC共刺激分子的表达,并且因此,由病毒血症HIV-1感染个体产生的mDC的IL-10的弱产生可能部分地促成显著功能失调的mDC的成熟表型。 NK细胞被认为通过其影响响应于抗原摄取而经历成熟的DC的质量的独特且可能更重要的机制是通过杀死未能完成其成熟程序的iDC。最近的一项研究表明,从病毒血症的HIV-1感染患者产生的DC可以逃避自体NK细胞的裂解,但这种逃避的根本原因尚未确定。在本研究中,我们描述了导致NK细胞介导的自体iDC裂解受损的细胞机制,并表明这种现象仅限于那些持续高病毒血症的HIV-1感染个体。我们的数据表明,NKp 30和TRAIL的表达/分泌和功能显著受损,这在很大程度上解释了由病毒血症HIV-1感染受试者产生的自体iDC的高度缺陷的NK细胞介导的裂解。此外,我们表明,在该研究组中,表达不寻常的KIRpos/NKG 2Aneg/NKp 30 neg/TRAILneg表型的CD 56 neg NK细胞的高度扩增,该亚群在病毒血症的HIV-1感染患者或健康供体中以非常低的频率存在,这可能解释了为什么NK细胞对自体iDC的这种缺陷性消除仅限于HIV-1阳性病毒血症患者。 这种NK-DC串扰代表了所提出的先天免疫能够在次级淋巴器官中引发有效的适应性免疫应答的机制。与HIV-1病毒血症患者和未感染的对照受试者相比,慢性HIV-1感染病毒血症个体中高度缺陷的双向NK-DC串扰可能在HIV-1发病机制的背景下导致病毒从协调的先天性和适应性免疫应答中逃逸。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anthony S. Fauci其他文献

Thoracic Mass Lesions in Immuno-incompetent Patients
  • DOI:
    10.1378/chest.82.2.164
  • 发表时间:
    1982-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    Michael R. Johnston;Phillip A. Pizzo;Anthony S. Fauci
  • 通讯作者:
    Anthony S. Fauci
Diadenosine 5‘,5“‘-<em>p</em>,<em>p</em><sup>4</sup>-Tetraphosphate Deficiency in Blood Platelets of the Chédiak-Higashi Syndrome
  • DOI:
    10.1182/blood.v66.3.735.735
  • 发表时间:
    1985-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Byung K. Kim;Francis C. Chao;Randi Leavitt;Anthony S. Fauci;Kenneth M. Meyers;Paul C. Zamecnik
  • 通讯作者:
    Paul C. Zamecnik
RNA vaccines: A transformational advance.
RNA 疫苗:革命性的进步。
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    32.4
  • 作者:
    Brian D. Brown;Anthony S. Fauci;Y. Belkaid;M. Merad
  • 通讯作者:
    M. Merad
Re-emergence of HIV after stopping therapy
停止治疗后艾滋病病毒的再次出现
  • DOI:
    10.1038/44755
  • 发表时间:
    1999-10-28
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Tae-Wook Chun;Richard T. Davey;Delphine Engel;H. Clifford Lane;Anthony S. Fauci
  • 通讯作者:
    Anthony S. Fauci
What keeps me up at night
是什么让我彻夜难眠

Anthony S. Fauci的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anthony S. Fauci', 18)}}的其他基金

Role Of Hiv Disease In The Pathogenesis Of Hepatitis B
艾滋病毒疾病在乙型肝炎发病机制中的作用
  • 批准号:
    6507015
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Role Of Hiv Envelope Protein In Replication/Pathogenesis
HIV包膜蛋白在复制/发病机制中的作用
  • 批准号:
    6507017
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Role Of Innate Immunity In The Initiation And Pathogenes
先天免疫在起始和病原体中的作用
  • 批准号:
    6986990
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Interaction of HIV envelope with cell surface receptors
HIV 包膜与细胞表面受体的相互作用
  • 批准号:
    8555852
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Interaction of HIV envelope with cell surface receptors
HIV 包膜与细胞表面受体的相互作用
  • 批准号:
    7964440
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Interaction of HIV envelope with cell surface receptors
HIV 包膜与细胞表面受体的相互作用
  • 批准号:
    8946348
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Role of Viral Reservoirs in the Pathogenesis of HIV Disease
病毒库在 HIV 疾病发病机制中的作用
  • 批准号:
    9161520
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Role of Viral Reservoirs in the Pathogenesis of HIV Disease
病毒库在 HIV 疾病发病机制中的作用
  • 批准号:
    8745373
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Role of Viral Reservoirs in the Pathogenesis of HIV Disease
病毒库在 HIV 疾病发病机制中的作用
  • 批准号:
    7732546
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Role of B Lymphocytes In HIV Infection And Pathogenesis
B 淋巴细胞在 HIV 感染和发病机制中的作用
  • 批准号:
    7732537
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似国自然基金

全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
  • 批准号:
    QN25H220002
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    15.0 万元
  • 项目类别:
    省市级项目
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造 血干细胞生成中的作用及机制研究
  • 批准号:
    TGY24H080011
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于In-cell NMR策略对“舟楫之剂”桔梗中引经药效物质的快速发现研究
  • 批准号:
    82305053
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
面向Cell-Free网络的协同虚拟化与动态传输
  • 批准号:
    62371367
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
Cell-in-cell促进曲妥珠单抗耐药乳腺癌细胞转移的作用与分子机制
  • 批准号:
    82373069
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
基于Multi-Pass Cell的高功率皮秒激光脉冲非线性压缩关键技术研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于定点突变膜受体Cell-free合成生物色谱新方法的PDGFRβ抑制剂筛选和结合位点分析
  • 批准号:
    82273886
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
FLRT3抑制异质性cell-in-cell结构形成机制及细胞免疫调节作用研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    51 万元
  • 项目类别:
    面上项目
基于Cell-SELEX 的磁珠富集技术与LAMP 联合构建的梅毒螺旋体核酸检测方法及其临床应用
  • 批准号:
    2021JJ30609
  • 批准年份:
    2021
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目

相似海外基金

SBIR Phase I: Endogenously secreted bispecific natural killer cell engagers (BIKEs) for therapy of solid tumors
SBIR I 期:用于治疗实体瘤的内源性分泌双特异性自然杀伤细胞接合剂 (BIKE)
  • 批准号:
    2322959
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Human Leukocyte Antigen-A and -B regulation of Natural Killer cell function
人类白细胞抗原 A 和 B 对自然杀伤细胞功能的调节
  • 批准号:
    DP230103117
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Discovery Projects
Targeting aerobic glycolysis via hexokinase 2 inhibition in Natural Killer T cell lymphomas
通过抑制己糖激酶 2 靶向自然杀伤 T 细胞淋巴瘤中的有氧糖酵解
  • 批准号:
    23K07830
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Peptide-Specific Natural Killer Cell Receptors in Health and Disease
健康和疾病中的肽特异性自然杀伤细胞受体
  • 批准号:
    MR/X020746/1
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Regulation of natural killer cell-mediated immune response in breast cancer
自然杀伤细胞介导的乳腺癌免疫反应的调节
  • 批准号:
    494926
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
Leveraging natural and engineered genetic barcodes from single cell RNA sequencing to investigate cellular evolution, clonal expansion, and associations between cellular genotypes and phenotypes
利用单细胞 RNA 测序中的天然和工程遗传条形码来研究细胞进化、克隆扩增以及细胞基因型和表型之间的关联
  • 批准号:
    10679186
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Sex Specific Regulation of B1 B Cell Self-Renewal and Natural Antibody Production
B1 B 细胞自我更新和天然抗体产生的性别特异性调节
  • 批准号:
    10751901
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Mechanisms of natural killer cell resistance of treatment-persistent residual tumor cells in hematologic malignancies
血液系统恶性肿瘤中持续治疗残留肿瘤细胞的自然杀伤细胞耐药机制
  • 批准号:
    10564354
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
The natural killer cell response against mouse cytomegalovirus infection
自然杀伤细胞对小鼠巨细胞病毒感染的反应
  • 批准号:
    10669344
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Elucidation of Human Natural Killer Cell Development
人类自然杀伤细胞发育的阐明
  • 批准号:
    10587566
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了